Mateon Therapeutics
NASDAQ: MATN
CEO: Bill Schwieterman
THIS INTERVIEW HAS EXPIRED
Mateon Therapeutics
NASDAQ: MATN
CEO: Bill Schwieterman
THIS INTERVIEW HAS EXPIRED
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com